Genetic variants and haplotypes of the Caspase-8 and Caspase-10 genes contribute to susceptibility to cutaneous melanoma

Human Mutation

Volumn 29, Issue 12, 2008, Pages 1443-1451

  Li, Chunying ^a,c   Zhao, Hui ^a   Hu, Zhibin ^a   Liu, Zhensheng ^a   Wang, Li E ^a   Gershenwald, Jeffrey E ^a   Prieto, Victor G ^a   Lee, Jeffrey E ^a   Duvic, Madeleine ^b   Grimm, Elizabeth A ^a   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Texas Health Science Center at Houston   (United States)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; CASP10; CASP8; Death pathway; Genetic susceptibility; Molecular epidemiology; Skin cancer

Indexed keywords

BIOLOGICAL MARKER; CASPASE 10; CASPASE 8;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CASPASE 10; CASPASE 8; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN NEOPLASMS; YOUNG ADULT;

EID: 57149094871     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20803     Document Type: Article

References (42)

1. Agresti A. 2002. Categorical data analysis. New York: Wiley-Interscience.
2. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton Jr A, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF. 2001. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-3648.
3. Banerjee G, Gupta N, Kapoor A, Raman G. 2005. UV induced bystander signaling leading to apoptosis. Cancer Lett 223:275-284.
4. Bohm M, Wolff I, Scholzen TE, Robinson SJ, Healy E, Luger TA, Schwarz T, Schwarz A. 2005. alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 280:5795-5802.
5. Brennan P, Lewis S, Hashibe M, Bell DA, Boffetta P, Bouchardy C, Caporaso N, Chen C, Coutelle C, Diehl SR, Hayes RB, Olshan AF, Schwartz SM, Sturgis EM, Wei Q, Zavras AI, Benhamou S. 2004. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol 159:1-16.
6. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MR, Giles GG, Fletcher O, Johnson N, dos Santos Silva I, Gibson L, Bojesen SE, Nordestgaard BG, Axelsson CK, Torres D, Hamann U, Justenhoven C, Brauch H, Chang-Claude J, Kropp S, Risch A, Wang-Gohrke S, Schürmann P, Bogdanova N, Dörk T, Fagerholm R, Aaltonen K, Blomqvist C, Nevanlinna H, Seal S, Renwick A, Stratton MR, Rahman N, Sangrajrang S, Hughes D, Odefrey F, Brennan P, Spurdle AB, Chenevix-Trench G; Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Beesley J, Mannermaa A, Hartikainen J, Kataja V, Kosma VM, Couch FJ, Olson JE, Goode EL, Broeks A, Schmidt MK, Hogervorst FB, Van't Veer LJ, Kang D, Yoo KY, Noh DY, Ahn SH, Wedrén S, Hall P, Low YL, Liu J, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Sigurdson AJ, Stredrick DL, Alexander BH, Struewing JP, Pharoah PD, Easton DF; Breast Cancer Association Consortium. 2007. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39:352-358.
7. Cryns V, Yuan J. 1998. Proteases to die for. Genes Dev 12:1551-1570.
8. Danial NN, Korsmeyer SJ. 2004. Cell death: critical control points. Cell 116:205-219.
9. Feigelson HS, Cox DG, Cann HM, Wacholder S, Kaaks R, Henderson BE, Albanes D, Altshuler D, Berglund G, Berrino F, Bingham S, Buring JE, Burtt NP, Calle EE, Chanock SJ, Clavel-Chapelon F, Colditz G, Diver WR, Freedman ML, Haiman CA, Hankinson SE, Hayes RB, Hirschhorn JN, Hunter D, Kolonel LN, Kraft P, LeMarchand L, Linseisen J, Modi W, Navarro C, Peeters PH, Pike MC, Riboli E, Setiawan VW, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D. 2006. Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res 66:2468-2475.
10. Fischer U, Stroh C, Schulze-Osthoff K. 2006. Unique and overlapping substrate specificities of caspase-8 and caspase-10. Oncogene 25:152-159.
11. Fitzpatrick TB. 1988. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124:869-871.
12. Frank B, Bermejo JL, Hemminki K, Klaes R, Bugert P, Wappenschmidt B, Schmutzler RK, Burwinkel B. 2005. Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 97:1012; author reply 1012-1013.
13. Frank B, Hemminki K, Wappenschmidt B, Meindl A, Klaes R, Schmutzler RK, Bugert P, Untch M, Bartram CR, Burwinkel B. 2006. Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 27:606-609.
14. Gilchrest BA, Eller MS, Geller AC, Yaar M. 1999. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340:1341-1348.
15. Goodman JE, Mechanic LE, Luke BT, Ambs S, Chanock S, Harris CC. 2006. Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer 118:1790-1797.
16. Green DR, Droin N, Pinkoski M. 2003. Activation-induced cell death in T cells. Immunol Rev 193:70-81.
17. Grenet J, Teitz T, Wei T, Valentine V, Kidd VJ. 1999. Structure and chromosome localization of the human CASP8 gene. Gene 226:225-232.
18. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:770-776.
19. Honghu Liu TW. 2003. Estimating the area under a receiver operating characteristic curve for repeated measures design. J Stat Softw 8:1-18.
20. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. 2007. Cancer statistics, 2007. CA Cancer J Clin 57:43-66.
21. Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D. 2007. The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett 245:61-68.
22. Juo P, Kuo CJ, Yuan J, Blenis J. 1998. Essential requirement for caspase-8/ FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 8:1001-1008.
23. Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D, Ashkenazi A. 2001. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 276:46639-46646.
24. Li C, Larson D, Zhang Z, Liu Z, Strom SS, Gershenwald JE, Prieto VG, Lee JE, Ross MI, Mansfield PF, Cormier JN, Duvic M, Grimm EA, Wei Q. 2006. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics 16:253-263.
25. Li C, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei Q. 2008. Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: A case-control study. Int J Cancer 122:2077-2084.
26. MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MW, Pharoah PD, Ponder BA, Meuth M, Bhattacharyya NP, Cox A. 2004. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 96:1866-1869.
27. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794-2804.
28. Prunell GF, Arboleda VA, Troy CM. 2005. Caspase function in neuronal death: delineation of the role of caspases in ischemia. Curr Drug Targets CNS Neurol Disord 4:51-61.
29. Schwarz T. 2005. Mechanisms of UV-induced immunosuppression. Keio J Med 54:165-171.
30. Shin MS, Kim HS, Kang CS, Park WS, Kim SY, Lee SN, Lee JH, Park JY, Jang JJ, Kim CW, Kim SH, Lee JY, Yoo NJ, Lee SH. 2002. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 99:4094-4099.
31. Son JW, Kang HK, Chae MH, Choi JE, Park JM, Lee WK, Kim CH, Kim DS, Kam S, Kang YM, Park JY. 2006. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet 169:121-127.
32. Soung YH, Lee JW, Kim SY, Sung YJ, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH. 2005. Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene 24:141-147.
33. Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM. 2007. Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis 28:1680-1686.
34. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
35. Stephens M, Scheet P. 2005. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 76:449-462.
36. Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, Guo Y, Yang M, Zhang X, Zhang Q, Zeng C, Lin D. 2007. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 39:605-613.
37. Takita J, Yang HW, Bessho F, Hanada R, Yamamoto K, Kidd V, Teitz T, Wei T, Hayashi Y. 2000. Absent or reduced expression of the caspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma. Med Pediatr Oncol 35:541-543.
38. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. 2004. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442.
39. Wang Y, Li G. 2006. ING3 promotes UV-induced apoptosis via Fas/caspase-8 pathway in melanoma cells. J Biol Chem 281:11887-11893.
40. Wang LE, Hsu TC, Xiong P, Strom SS, Duvic M, Clayman GL, Weber RS, Lippman SM, Goldberg LH, Wei Q. 2007. 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis. J Invest Dermatol 127:196-205.
41. Wei Q, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Strom SS, Wang LE, Guo Z, Qiao Y, Amos CI, Spitz MR, Duvic M. 2003. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 95:308-315.
42. Yang X, Chang HY, Baltimore D. 1998. Autoproteolytic activation of pro-caspases by oligomerization. Mol Cell 1:319-325.